Amongst patients with diabetes, the most common diabetes medications were insulin and insulin analogs (53.7%), biguanides (40.8%), and sulfonylureas (22.3%); use of sodium–glucose co-transporter inhibitors (3.2%) and glucagon-like peptide-1 receptor agonists (1.1%) was less common. This evidence concerns the gene INS and diabetes mellitus.